Kobayashi Pharmaceutical Co., Ltd. recognizes that reducing the investment unit is an effective measure to expand the investor base and revitalize the stock market, and has indicated a policy to consider this appropriately based on future market trends.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4967","jir_company_name":"Kobayashi Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-03-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4967-20260327-01.pdf","jir_short_summary":"Kobayashi Pharmaceutical Co., Ltd. recognizes that reducing the investment unit is an effective measure to expand the investor base and revitalize the stock market, and has indicated a policy to consider this appropriately based on future market trends.","jir_summary":"### Approach Regarding the Reduction of Investment Unit\nKobayashi Pharmaceutical Co., Ltd. recognizes that reducing the investment unit is a useful measure that contributes to expanding the investor base and revitalizing the stock market. It is expected that this will make it easier for more investors to acquire shares.\n\n### Policy Regarding the Reduction of Investment Unit\nRegarding the specific implementation of the reduction, the company indicates a policy to consider it appropriately in a comprehensive manner, reflecting future stock market trends, the price level of the company\u2019s shares, and changes in shareholder composition. The specific timing and content of implementation are undecided at this point.","jir_financial_highlights":"Policy on Reduction of Investment Unit: To be considered (Unknown)","jir_category":"","jir_hashtags":"#KobayashiPharmaceutical, #CapitalPolicy, #InvestmentUnitReduction","jir_key_figures":"Start of consideration for reduction of investment unit: Unknown (to be considered)\nImplementation timing: Unknown\nConsideration of stock price level and changes in shareholder composition: Stated","jir_meta_title":"Kobayashi Pharmaceutical Announces Approach and Policy on Investment Unit Reduction and Plans for Future Consideration","jir_meta_description":"Kobayashi Pharmaceutical Co., Ltd. recognizes that reducing the investment unit is effective for expanding the investor base and revitalizing the market, and announced a policy to consider it appropriately based on future market trends.","jir_og_title":"Kobayashi Pharmaceutical Announces Policy on Investment Unit Reduction","jir_og_description":"Kobayashi Pharmaceutical announced its approach and policy on reducing the investment unit and plans to consider it in light of future market trends.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7982,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-37352","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n